경카테터 심장판막 치환술 시장 규모, 점유율, 성장 분석 : 제품별, 수술 접근 방식별, 최종 용도별, 적용 분야별, 지역별 - 업계 예측(2026-2033년)

Transcatheter Heart Valve Replacement Market size was valued at USD 7.5 Billion in 2024 and is poised to grow from USD 8.6 Billion in 2025 to USD 25.78 Billion by 2033, growing at a CAGR of 14.7% during the forecast period (2026-2033).

The transcatheter heart valve replacement market is experiencing significant growth as it emerges as a preferred alternative to traditional open-heart surgery, particularly for patients with severe aortic valve disease. With procedures like TAVR, which involves implanting a prosthetic valve through catheterization, significant benefits include reduced surgical risks, shorter hospital stays, and faster recovery times. This approach is especially valuable for high-risk or previously inoperable patients. Key drivers of market expansion include technological innovations, a widening patient demographic, and increased acceptance among healthcare practitioners. The aging population and heightened incidence of cardiovascular conditions further amplify demand for TAVR. Continuous investment in research and development from manufacturers aims to enhance valve designs and procedural techniques, ultimately promising improved patient outcomes and quality of life in cardiovascular care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Transcatheter Heart Valve Replacement market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Transcatheter Heart Valve Replacement Market Segments Analysis

Global Transcatheter Heart Valve Replacement Market is segmented by product, surgical approach, end-use, application and region. Based on product, the market is segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement and transcatheter aortic valve replacement. Based on surgical approach, the market is segmented into transapical approach, transfemoral approach and others. Based on end-use, the market is segmented into cath labs and hospitals. Based on application, the market is segmented into pulmonary valvular heart disease, mitral valvular heart disease and aortic valvular heart disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Transcatheter Heart Valve Replacement Market

The growing prevalence of heart valve diseases, particularly aortic stenosis, is significantly influenced by the aging population worldwide, leading to heightened demand for transcatheter heart valve replacement (THVR). As individuals age, they are more susceptible to developing valve-related conditions, which in turn expands the number of patients seeking THVR interventions. This demographic shift toward an older population not only increases the incidence of heart valve issues but also emphasizes the need for effective, minimally invasive solutions such as THVR, ultimately shaping the market landscape for these advanced cardiac treatments. The demand for THVR is thus on the rise, reflecting these societal trends.

Restraints in the Transcatheter Heart Valve Replacement Market

The Transcatheter Heart Valve Replacement market faces several constraints, primarily due to the high initial costs involved in these procedures. The expenses related to the devices and the necessary specialized equipment can be significant, which may deter healthcare providers from adopting these technologies. Furthermore, inconsistencies in reimbursement policies and varying regulations across different regions can complicate the financial aspects, ultimately limiting patient access to these advanced treatments. These factors collectively pose challenges that may impede the growth and wider acceptance of transcatheter heart valve replacement solutions in the healthcare market.

Market Trends of the Transcatheter Heart Valve Replacement Market

The Transcatheter Heart Valve Replacement (THVR) market is experiencing a dynamic evolution characterized by rapid technological advancements that are transforming patient care. The emergence of sophisticated valve designs, cutting-edge imaging modalities, and enhanced delivery mechanisms is facilitating more effective and less invasive procedures. These innovations are not only minimizing risks and complications but also broadening the demographic of patients eligible for treatment. Consequently, the growing preference for THVR over traditional surgical options is rapidly reshaping treatment paradigms for aortic valve diseases, propelling market expansion and fostering increased adoption among healthcare providers globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Transcatheter Heart Valve Replacement Market Size by Product & CAGR (2026-2033)

• Market Overview
• Transcatheter Pulmonary Valve Replacement
• Transcatheter Mitral Valve Repair & Replacement
• Transcatheter Aortic Valve Replacement

Global Transcatheter Heart Valve Replacement Market Size by Surgical Approach & CAGR (2026-2033)

• Market Overview
• Transapical Approach
• Transfemoral Approach
• Others

Global Transcatheter Heart Valve Replacement Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Cath Labs
• Hospitals

Global Transcatheter Heart Valve Replacement Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pulmonary Valvular Heart Disease
• Mitral Valvular Heart Disease
• Aortic Valvular Heart Disease

Global Transcatheter Heart Valve Replacement Market Size & CAGR (2026-2033)

• North America (Product, Surgical Approach, End-Use, Application)
  • US
  • Canada
• Europe (Product, Surgical Approach, End-Use, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Surgical Approach, End-Use, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Surgical Approach, End-Use, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Surgical Approach, End-Use, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYMETIS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suzhou Jiecheng Medical Technology Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blue Sail Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HighLife SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations